Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / BIOTECHNOLOGY
-
Total 13F shares
-
925,697
-
Share change
-
+13,293
-
Total reported value
-
$52,523,167
-
Price per share
-
$56.62
-
Number of holders
-
71
-
Value change
-
+$730,115
-
Number of buys
-
21
-
Number of sells
-
28
Institutional Holders of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) as of Q3 2020
As of 30 Sep 2020,
INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) was held by
71 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
925,697 shares.
The largest 10 holders included
MORGAN STANLEY, WELLS FARGO & COMPANY/MN, ROYAL BANK OF CANADA, BANK OF AMERICA CORP /DE/, ADVISOR GROUP HOLDINGS, INC., LPL Financial LLC, CITADEL ADVISORS LLC, UBS Group AG, Anfield Capital Management, LLC, and PFG Advisors.
This page lists
71
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.